<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shi, Zhiqiang</style></author><author><style face="normal" font="default" size="100%">Lu, Yongjin</style></author><author><style face="normal" font="default" size="100%">Zhao, Qiuchen</style></author><author><style face="normal" font="default" size="100%">Wang, Yongsheng</style></author><author><style face="normal" font="default" size="100%">Qiu, Pengfei</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Antibody-drug conjugates in breast cancer: advances and prospects</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Biology &amp;amp; Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2025-02-15 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">83-92</style></pages><doi><style  face="normal" font="default" size="100%">10.20892/j.issn.2095-3941.2024.0486</style></doi><volume><style face="normal" font="default" size="100%">22</style></volume><issue><style face="normal" font="default" size="100%">2</style></issue><abstract><style  face="normal" font="default" size="100%">You do not have access to the full text of this article, the first page of the PDF of this article appears above.</style></abstract></record></records></xml>